Cancer Vaccinology and Preventive Vaccines

Cancer Vaccinology and Preventive Vaccines focus on developing vaccines that either prevent cancer or stimulate the immune system to fight existing cancer cells. Preventive vaccines are designed to protect against viruses known to cause cancer, such as the HPV vaccine (human papillomavirus), which helps prevent cervical, throat, and other cancers, or the Hepatitis B vaccine, which reduces the risk of liver cancer. Cancer vaccinology also explores therapeutic vaccines aimed at treating existing cancers by stimulating the immune system to target and destroy tumor cells. These vaccines are personalized to recognize specific cancer antigens and can be used in combination with other cancer treatments, offering a promising avenue for both cancer prevention and treatment.

    Related Conference of Cancer Vaccinology and Preventive Vaccines

    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    April 07-08, 2025

    15th World Congress on Breast Cancer

    Vancouver, Canada
    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Aix-en-Provence, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain

    Cancer Vaccinology and Preventive Vaccines Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in